Pomerantz Law Firm Investigates Claims Involving Foghorn Therapeutics Investors
Pomerantz Law Firm said it is investigating claims on behalf of Foghorn Therapeutics investors.
Related stories
PAG to Acquire 51% Stake in Evergrande Property Services for $514 Million
PAG will acquire a 51% stake for HK$4.03 billion ($513.64 million), Evergrande Property Services said. The offer values 5.52 billion shares at HK$0.8359 each, a 29% discount to the
M impact | EQUITY | Oct 30, 2026, 12:19 AM UTC
SoftBank Group shares fall 5.7%
M impact | EQUITY | Oct 30, 2026, 12:09 AM UTC
Arthur J. Gallagher Reports Quarterly Results
Arthur J. Gallagher reported results for the quarter ended September 30; the available report provides no figures.
M impact | EQUITY | Oct 30, 2026, 12:09 AM UTC
Bayer Wins Trial in Roundup Cancer Cases
Bayer won a trial involving allegations that Roundup caused cancer in three women.
M impact | EQUITY | Oct 30, 2026, 12:08 AM UTC
Advantest shares fall 5.6%
M impact | EQUITY | Oct 30, 2026, 12:07 AM UTC
Japan's Nikkei Share Average Falls 1.1%
M impact | EQUITY | Oct 30, 2026, 12:06 AM UTC